GlobeNewswire by notified

DSV, 1070 - SHARE BUYBACK IN DSV A/S

Share

Company Announcement No. 1070

On 24 October 2023, we initiated a share buyback programme, as described in Company Announcement No. 1066. According to the programme, the company will in the period from 24 October 2023 until 31 January 2024 purchase own shares up to a maximum value of DKK 2,500 million, and no more than 4,000,000 shares, corresponding to 1.83% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save for the rules on share buyback programmes set out in MAR article 5) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.

The following transactions have been recorded under the programme:

Trading dayTrading platformNumber of shares bought backAverage transaction price DKKAmount DKK
Accumulated trading for days 1-4

155,123

1,006.24

156,091,289

5:30 October 2023AQEU2,660998.43
CEUX9,256994.14
TQEX3,588993.91
XCSE20,165991.16
Total35,669992.7535,410,453
6:31 October 2023AQEU1,4321,050.85
CEUX4,2231,045.60
TQEX1,2461,049.91
XCSE20,0991,043.07
Total27,0001,044.2028,193,270
7:1 November 2023AQEU1,8841,056.86
CEUX5,8411,057.73
TQEX8831,058.17
XCSE21,3921,057.18
Total30,0001,057.3031,718,907
8:2 November 2023AQEU4771,064.24
CEUX1,3271,079.29
TQEX1031,058.20
XCSE5,5611,080.88
Total7,4681,079.228,059,606
9:3 November 2023AQEU9,5211,087.95
CEUX38,6751,088.21
TQEX9,1751,088.24
XCSE62,6291,086.99
Total120,0001,087.56130,506,828
Accumulated trading for days 1-9375,260 1,039.23 389,980,353

After the disclosed transactions, DSV A/S holds a total of 8,558,410 shares of a nominal value of DKK 1 in DSV A/S, corresponding to 3.91% of the total number of issued shares of 219,000,000.

The details of each transaction made under the share buyback programme are published on investor.dsv.com.

Any questions may be addressed to Executive Vice President, Investor Relations, Flemming Ole Nielsen, tel. +45 43 20 33 92.

Yours sincerely,
DSV A/S

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Dividend Declaration7.12.2023 08:00:00 CET | Press release

Volta Finance Limited (VTA/VTAS) Dividend Declaration NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES Guernsey, 7 December 2023 Volta Finance Limited ("the Company") hereby announces that it has declared a quarterly interim dividend of €0.135 per share payable on 25 January 2024 amounting to approximately €4.94 million, approximately equating to an annualised 8.25% of net asset value. The ex-dividend date is 21 December 2023 with a record date of 22 December 2023. The Company has arranged for its shareholders to be able to elect to receive their dividends in either Euros or Pounds Sterling. Shareholders will, by default, receive their dividends in Euros, unless they have instructed the Company’s Registrar, Computershare Investor Services (Guernsey) Limited (“Computershare”), to pay dividends in Pounds Sterling. Such instructions may be given to Computershare either electronically via CREST or by using the Currency Election Form which has

Tag Systems and Fingerprint Cards AB (Fingerprints™) to bring biometric card to market7.12.2023 08:00:00 CET | Press release

Global card manufacturer Tag Systems (part of AUSTRIACARD Holdings AG) has achieved Mastercard certification for its biometric card based on Fingerprint Cards’ sensor and STMicroelectronics STPay-Topaz-Bio solution. Banks and fintechs can now issue Mastercard-branded biometric payment cards to enhance convenience and security for cardholders. Roger Carrico, Vice President, Head of Sales & Business development, Payment & Access at Fingerprints comments: “In Tag Systems we have a partner that likes to lead the way with high-end payment services. Banks and fintechs can take advantage of the opportunity to differentiate, retain and acquire customers and drive revenues.” Jon Neeraas, CEO at Tag Systems adds: “With this certification, we are excited to support our partners in issuing top-of-wallet biometric cards that utilize Fingerprints and ST latest technologies. Together, we are creating convenient, hygienic, and secure transactions for all purchases.” Following a partnership agreement i

MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial7.12.2023 08:00:00 CET | Press release

MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial MC2-25 CKD is a first-in-class drug candidate and a potential breakthrough in the understanding and treatment of urea associated skin diseases that has puzzled scientists for decadesMC2-25 CKD uses a di-peptide as an iso-cyanate scavenger to inhibit carbamylation of amino acids and proteins in the skinMC2-25 CKD has the potential to become the world’s first approved treatment for pre-dialysis Chronic Kidney Disease-associated Pruritus (CKD-aP), a debilitating condition thought to affect a significant proportion of the ~800 million people globally who suffer from Chronic Kidney Disease (CKD)111 patients enrolled in the multi-center trial across Europe with topline results expected in Q2 2024 Copenhagen, December 7th, 2023 – MC2 Therapeutics, a commercial stage biotech company focused on developing novel treatment paradigms within immune-mediated and inflammatory conditions,

Sanoma Corporation - Managers' Transactions7.12.2023 08:00:00 CET | Press release

Sanoma Corporation, Managers’ Transactions, 7 December 2023 at 9:00 EET Sanoma Corporation - Managers' Transactions ___________________________________________ Person subject to the notification requirement Name: Holding Manutas Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Anna Herlin Position: Member of the Board Issuer: Sanoma Oyj LEI: 743700XJC24THUPK0S03 Notification type: INITIAL NOTIFICATION Reference number: 45422/5/6 ____________________________________________ Transaction date: 2023-12-05 Venue: BEUP Instrument type: SHARE ISIN: FI0009007694 Nature of transaction: ACQUISITION Transaction details (1): Volume: 2494 Unit price: 6.92 EUR Aggregated transactions (1): Volume: 2494 Volume weighted average price: 6.92 EUR ____________________________________________ Transaction date: 2023-12-05 Venue: CEUX Instrument type: SHARE ISIN: FI0009007694 Nature of transaction: ACQUISITION Transaction details (1): V

PGS Contract Award in Asia Pacific7.12.2023 08:00:00 CET | Press release

December 7, 2023, Oslo, Norway: PGS is awarded a 3D exploration contract in Asia Pacific. The Ramform Sovereign is scheduled to mobilize for the survey in December and the contract has a total duration of approximately 50 days. “We are very pleased with this contract award securing work for the Ramform Sovereign into first quarter next year. Most of our activities in Asia Pacific this year have been well pre-funded MultiClient projects. Now we are experiencing increasing contract tendering activity and see potential for more proprietary work in the region,” says Rune Olav Pedersen, President & CEO in PGS. PGS announces contract awards and MultiClient projects as stock exchange releases if the contract has a value of $10 million or more, MultiClient projects with a duration of 2 months or more, and strategically important contracts. FOR DETAILS, CONTACT:Bård Stenberg, VP IR & Corporate Communication Mobile: +47 992 45 235 *** PGS ASA and its subsidiaries (“PGS” or “the Company”) is a fu